[Effect of a new oral remedy for a cold (HSP 525 A) on flow resistance of the nose].
D000284:Administration, Oral; D000328:Adult; D000605:Amino Alcohols / Q000494:pharmacology*; D002974:Clemastine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D009297:Nasal Mucosa / Q000187:drug effects*; D010627:Phenethylamines / Q000494:pharmacology*; D010665:Phenylpropanolamine / Q000494:pharmacology; D010919:Placebos; D010993:Plethysmography, Whole Body; D011759:Pyrrolidines / Q000494:pharmacology*; D012494:Sampling Studies; D013566:Sympathomimetics / Q000494:pharmacology*
D000605:Amino Alcohols; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D010627:Phenethylamines; D010919:Placebos; D011759:Pyrrolidines; D013566:Sympathomimetics; D010665:Phenylpropanolamine; D006632:Histamine; D002974:Clemastine
Die Wirkung eines neuen, oralen Schnupfenmittels (HSP 525 A) auf den Stromungswiderstand der Nase.